Interferon and cytokine responses to SARS-coronavirus infection

被引:125
作者
Thiel, Volker [2 ]
Weber, Friedemann [1 ]
机构
[1] Univ Freiburg, Inst Med Mikrobiol & Hyg, Abt Virol, D-79008 Freiburg, Germany
[2] Kantonal Hosp, Res Dept, St Gallen, Switzerland
关键词
SARS; coronaviruses; interferon; chemokines; viral countermeasures;
D O I
10.1016/j.cytogfr.2008.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The sudden emergence of severe acute respiratory syndrome (SARS) has boosted research on innate immune responses to coronaviruses. It is now well established that the causative agent, a newly identified coronavirus termed SARS-CoV, employs multiple passive and active mechanisms to avoid induction of the antiviral type I interferons in tissue cells. By contrast, chemokines such as IP-10 or IL-8 are strongly upregulated. The imbalance in the IFN response is thought to contribute to the establishment of viremia early in infection, whereas the production of chemokines by infected organs may be responsible for (i) massive immune cell infiltrations found in the lungs of SARS victims, and (ii) the dysregulation of adaptive immunity. Here, we will review the most recent findings on the interaction of SARS-CoV and related Coronaviridae members with the type I interferon and cytokine responses and discuss implications for pathogenesis and therapy. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:121 / 132
页数:12
相关论文
共 181 条
[1]   Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus [J].
Åkerström, S ;
Mousavi-Jazi, M ;
Klingström, J ;
Leijon, M ;
Lundkvist, Å ;
Mirazimi, A .
JOURNAL OF VIROLOGY, 2005, 79 (03) :1966-1969
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   The nucleoprotein is required for efficient coronavirus genome replication [J].
Almazán, F ;
Galán, C ;
Enjuanes, L .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12683-12688
[4]   Investigating the economic role of mergers [J].
Andrade, G ;
Stafford, E .
JOURNAL OF CORPORATE FINANCE, 2004, 10 (01) :1-36
[5]   Production of type I interferons: plasmacytoid dendritic cells and beyond [J].
Asselin-Paturel, C ;
Trinchieri, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) :461-465
[6]   Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis [J].
Aurisicchio, L ;
Delmastro, P ;
Salucci, V ;
Paz, OG ;
Rovere, P ;
Ciliberto, G ;
La Monica, N ;
Palombo, F .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4816-4823
[7]   Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon α genes [J].
Barnes, BJ ;
Moore, PA ;
Pitha, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :23382-23390
[8]  
BARTHOLD SW, 1993, LAB ANIM SCI, V43, P276
[9]   Coronavirus infection of the central nervous system: host-virus stand-off [J].
Bergmann, CC ;
Lane, TE ;
Stohlman, SA .
NATURE REVIEWS MICROBIOLOGY, 2006, 4 (02) :121-132
[10]   Severe acute respiratory syndrome, a pathological immune response to the new coronavirus -: Implications for understanding of pathogenesis, therapy, design of vaccines, and epidemiology [J].
Bermejo, JF ;
Muñoz-Fernandez, MA .
VIRAL IMMUNOLOGY, 2004, 17 (04) :535-544